Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Article

    Antimicrobial Activity of Syzygium australe and Syzygium leuhmannii Leaf Methanolic Extracts

    wadmin1By wadmin1April 1, 2012Updated:August 6, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    I.E. Cocka,b
    aEnvironmental Futures Centre, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, Australia.
    bBiomolecular and Physical Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, Australia

    Pharmacognosy Communications,2012,2,2,71-77
    DOI: 10.5530/pc.2012.2.11
    Published:April 2012
    Type: Research Letter

    ABSTRACT

    Introduction: Many species of Syzygium are known to have antiseptic activity. Australian Syzygium species had roles as traditional bush medicines for Australian Aborigines although their antiseptic potential has not been rigorously studied. Methods: The antimicrobial activity of methanolic extracts of Syzygium australe and Syzygium leuhmannii leaves was investigated by disc diffusion assay and growth time course assay against a panel of bacteria and fungi. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: S. australe leaf extract inhibited the growth of 10 of the 14 bacteria tested (71%). Gram-positive and Gram-negative bacteria were equally susceptible. 8 of the 11 Gram-negative bacteria (73%) and 2 of the 3 Gram-positive bacteria (67%) tested had their growth inhibited by S. australe leaf extract. The extract also displayed antifungal activity against a nystatin resistant strain of A. niger but did not affect C. albicans or S. cerevisiae growth. In comparison, S. leuhmannii leaf extract did not inhibit the growth of any of the microbial agents tested in the disc diffusion assay. The antibacterial activity of S. australe leaf extract was further investigated by growth time course assays which showed significant growth inhibition in cultures of A. hydrophilia, B. cereus, and P. fluorescens within 1 h but not of B. subtilis. S. leuhmannii also inhibited the growth of P. fluorescens and to a lesser extent, A. hydrophilia in the time course assay. Both Syzygium extracts displayed low toxicity in the Artemia franciscana bioassay. Conclusions: The low toxicity of these Syzygium extracts and the inhibitory bioactivity of S. australe against the bacterial panel validate Australian Aboriginal usage of S. australe leaves as antiseptic agents and confirms their medicinal potential.

    Key words: Syzygium australe, Syzygium leuhmannii, Australian plants, antibacterial activity, medicinal plants, toxicity

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up